From: Concordance and predictive value of two adverse drug event data sets
MedDRA top-level category | Lexi-comp 2010 | SIDER 2012 |
---|---|---|
AUROC (95% CI) | AUROC (95% CI) | |
Nervous system disorders | 0.85 (0.84 – 0.86) | 0.84 (0.84 – 0.85) |
Gastrointestinal disorders | 0.85 (0.84 – 0.86) | 0.84 (0.83 – 0.85) |
Skin and subcutaneous tissue disorders | 0.85 (0.84 – 0.86) | 0.85 (0.85 – 0.86) |
General disorders | 0.86 (0.84 – 0.87) | 0.76 (0.75 – 0.77) |
Respiratory, thoracic and mediastinal disorders | 0.80 (0.79 – 0.82) | 0.78 (0.77 – 0.79) |
Vascular disorders | 0.84 (0.83 – 0.86) | 0.83 (0.82 – 0.84) |
Psychiatric disorders | 0.83 (0.82 – 0.85) | 0.81 (0.81 – 0.82) |
Musculoskeletal and connective tissue disorders | 0.82 (0.80 – 0.84) | 0.83 (0.82 – 0.84) |
Eye disorders | 0.79 (0.77 – 0.81) | 0.83 (0.82 – 0.84) |
Infections and infestations | 0.85 (0.83 – 0.86) | 0.85 (0.84 – 0.86) |
Investigations | 0.86 (0.84 – 0.88) | 0.80 (0.79 – 0.81) |
Metabolism and nutrition disorders | 0.81 (0.79 – 0.83) | 0.82 (0.81 – 0.83) |
Blood and lymphatic system disorders | 0.87 (0.86 - 0.89) | 0.88 (0.87 – 0.88) |
Cardiac disorders | 0.83 (0.81 – 0.85) | 0.84 (0.82 – 0.85) |
Renal and urinary disorders | 0.86 (0.84 – 0.87) | 0.85 (0.83 – 0.86) |
Reproductive system and breast disorders | 0.85 (0.82 – 0.87) | 0.86 (0.84 – 0.87) |
Immune system disorders | 0.88 (0.87 – 0.90) | 0.90 (0.89 – 0.91) |
Neoplasms benign, malignant and unspecified | 0.80 (0.74 – 0.85) | 0.78 (0.76 – 0.80) |
Hepatobiliary disorders | 0.85 (0.83 – 0.88) | 0.83 (0.81 – 0.84) |
Injury, poisoning and procedural disorders | 0.86 (0.84 – 0.89) | 0.80 (0.78 – 0.82) |
Endocrine disorders | 0.82 (0.79 – 0.85) | 0.85 (0.83 – 0.86) |
Ear and labyrinth disorders | 0.86 (0.83 – 0.89) | 0.84 (0.82 – 0.86) |
Surgical and medical procedures | 0.82 (0.73 – 0.89) | 0.66 (0.60 – 0.72) |
Pregnancy, puerperium and perinatal conditions | 0.78 (0.63 – 0.93) | 0.74 (0.66 – 0.82) |
Congenital, familial and genetic disorders | 0.91 (0.83 – 0.98) | 0.60 (0.53 – 0.66) |